カテゴリ： Allied Market Research, 世界, 医療/バイオ

脊髄刺激装置のグローバル市場（2023-2032）：充電式装置、非充電式装置

■ 英語タイトル：Spinal Cord Stimulation Devices Market By Product (Rechargeable devices, Non-rechargeable devices), By Indication (Failed back surgery syndrome, Complex regional pain syndrome, Degenerative disc disease, Others), By End User (Hospitals, Ambulatory surgical centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23SEP138）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23SEP138
■ 発行日：2023年5月
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：258
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脊髄刺激装置のグローバル市場（2023-2032）：充電式装置、非充電式装置]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

脊髄刺激療法は、脊髄に電気インパルスを送る埋め込み型装置を使用する医療技術で、慢性疼痛状態の患者の痛みを軽減し、機能を改善することを目的としています。脊髄刺激装置は、腰の皮下に植え込まれる小型のバッテリー駆動発電機と、脊髄近くの硬膜外腔に植え込まれる1本以上のリード線で構成されています。リード線はジェネレーターに接続され、脊髄に電気インパルスを送り、痛みの信号が脳に到達するのを妨害または遮断します。脊髄刺激装置は、背部手術失敗症候群（FBSS）、複合性局所疼痛症候群（CRPS）、変性椎間板症（DDD）、有痛性糖尿病性神経障害（PDN）など、さまざまな症状の治療に用いられます。脊髄刺激装置にはさまざまなタイプやデザインがあり、機能や性能もさまざまです。充電式や非充電式など、さまざまなタイプの脊髄刺激装置は、さまざまな患者のニーズに対応し、カスタマイズされた治療オプションを提供するように設計されています。
脊髄刺激装置市場の成長を促進する主な要因は、慢性疼痛状態に苦しむ人々の増加、脊髄刺激装置の技術的進歩、脊髄刺激装置の採用増加です。慢性疼痛は、背部手術失敗症候群(FBSS)、複合性局所疼痛症候群(CRPS)、椎間板変性症(DDD)、糖尿病性神経障害など、さまざまな疾患によって引き起こされます。これらの疾患は衰弱させる可能性があり、人の生活の質に影響を及ぼし、長期的な管理が必要となります。脊髄刺激装置は、他の治療法に反応しない慢性疼痛状態に苦しむ患者にとって、効果的な治療オプションとして登場しました。さらに、脊髄刺激装置は脊髄に電気インパルスを送り、脳への痛み信号の伝達を遮断することで機能します。

さらに、脊髄刺激装置の技術的進歩により、装置は小型 化、柔軟化し、より効果的になりました。例えば、新しい装置は高周波刺激を使用し、従来の低周波刺激に関連するピリピリ感やチクチク感を引き起こすことなく疼痛緩和を提供することができます。さらに、充電式バッテリーやワイヤレス機器の開発など、患者の快適性や利便性を向上させる技術も進歩しています。患者や医師がより効果的で使い勝手のよい機器を求める中、こうした技術的進歩が脊髄刺激装置の需要を促進すると予想されます。

さらに、世界の人口は急速に高齢化しており、この人口動態の変化が脊髄刺激装置の需要を促進すると予想されます。高齢者は慢性的な疼痛症状に悩まされる可能性が高く、人口の高齢化に伴い、脊髄刺激療法を必要とする人の数は増加すると予想されます。例えば、米国国勢調査局（2022年）によると、米国には65歳以上の成人が5,600万人以上居住しており、これは全米人口の約16.9%を占めているため、老人人口の増加が市場の成長を促進すると予想されています。

脊髄刺激装置市場は、製品、適応症、エンドユーザー、地域に区分されます。製品ベースでは、市場は充電式機器と非充電式機器に二分されます。適応症別では、腰の手術失敗症候群、複合性局所疼痛症候群、変性椎間板症、その他に分類されます。エンドユーザー別では、病院、外来手術センター、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋）、LAMEA（中南米、中東アフリカ）で市場を分析します。
世界の脊髄刺激装置市場で事業を展開する主な主要企業は、Medtronic Plc、Boston Scientific Corporation、Abbott Laboratories、Nevro Corporation、Beijing PINS Medical Co.Ltd、Saluda Medical Pty Ltd.、Nalu Medical, Inc.、BIOTRONIK、GIMER MEDICAL、Teliatry, Inc.です。主要企業は、製品ポートフォリオを拡大するために、買収、製品発売、製品承認、事業拡大などの戦略を採用しています。

ステークホルダーにとっての主なメリット
本レポートは、2022年から2032年までの脊髄刺激装置市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢な脊髄刺激装置市場機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
脊髄刺激装置市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界別の脊髄刺激装置の市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
適応症別
腰部手術失敗症候群
複合性局所疼痛症候群
椎間板変性疾患
その他

製品別
充電式機器
非充電式機器

エンドユーザー別
病院
外来手術センター
その他

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
LAMEA
ラテンアメリカ
中東アフリカ

主な市場プレイヤー
○ Boston Scientific Corporation
○ Beijing PINS Medical Co., Ltd
○ Medtronic plc
○ Abbott Laboratories
○ BIOTRONIK SE & Co. KG
○ Saluda Medical Pty Ltd.
○ Nalu Medical, Inc.
○ GIMER MEDICAL
○ Teliatry, Inc.
○ Nevro Corporation

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：脊髄刺激装置市場、製品別
第5章：脊髄刺激装置市場、疾患別
第6章：脊髄刺激装置市場、エンドユーザー別
第7章：脊髄刺激装置市場、地域別
第8章：競争状況
第9章：企業情報

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic pain conditions
3.4.1.2. Technological advancements in spinal cord stimulation devices
3.4.1.3. Availability of medical reimbursement schemes

3.4.2. Restraints
3.4.2.1. High cost and side effects of spinal cord stimulation devices
3.4.2.2. Availability of alternative treatment options for chronic pain

3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Rechargeable devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Non-rechargeable devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Failed back surgery syndrome
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Complex regional pain syndrome
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Degenerative disc disease
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Middle East Africa
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Medtronic plc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Abbott Laboratories
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Nevro Corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Beijing PINS Medical Co., Ltd
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Saluda Medical Pty Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. Nalu Medical, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Teliatry, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. GIMER MEDICAL
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. BIOTRONIK SE & Co. KG
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 05. SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 06. SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 07. SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. UK SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. UK SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 39. UK SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 41. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 54. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 56. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 76. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 77. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 80. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 84. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
TABLE 91. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 92. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 93. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 94. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 95. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 96. NEVRO CORPORATION: KEY EXECUTIVES
TABLE 97. NEVRO CORPORATION: COMPANY SNAPSHOT
TABLE 98. NEVRO CORPORATION: PRODUCT SEGMENTS
TABLE 99. NEVRO CORPORATION: PRODUCT PORTFOLIO
TABLE 100. NEVRO CORPORATION: KEY STRATERGIES
TABLE 101. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 102. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 103. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 104. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 105. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
TABLE 106. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
TABLE 107. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
TABLE 108. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO
TABLE 109. SALUDA MEDICAL PTY LTD.: KEY STRATERGIES
TABLE 110. NALU MEDICAL, INC.: KEY EXECUTIVES
TABLE 111. NALU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 112. NALU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 113. NALU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 114. TELIATRY, INC.: KEY EXECUTIVES
TABLE 115. TELIATRY, INC.: COMPANY SNAPSHOT
TABLE 116. TELIATRY, INC.: PRODUCT SEGMENTS
TABLE 117. TELIATRY, INC.: PRODUCT PORTFOLIO
TABLE 118. GIMER MEDICAL: KEY EXECUTIVES
TABLE 119. GIMER MEDICAL: COMPANY SNAPSHOT
TABLE 120. GIMER MEDICAL: PRODUCT SEGMENTS
TABLE 121. GIMER MEDICAL: PRODUCT PORTFOLIO
TABLE 122. GIMER MEDICAL: KEY STRATERGIES
TABLE 123. BIOTRONIK SE & CO. KG: KEY EXECUTIVES
TABLE 124. BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 125. BIOTRONIK SE & CO. KG: PRODUCT SEGMENTS
TABLE 126. BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127. BIOTRONIK SE & CO. KG: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CAR-T細胞療法のグローバル市場（2023-2032）：アキシカブタゲンシロロイセル、チサゲンレクロイセル、ブレクスカブタジェンアウトルーセル、その他
  • T細胞療法のグローバル市場（2023-2032）：CART細胞療法、T細胞受容体（TCR）ベース
  • 薬物懸濁液のグローバル市場（2023-2032）：経口剤、非経口剤、その他
  • 眼内薬物送達のグローバル市場（2023-2032）：局所、眼内インサート、眼内インプラント、眼内ゲル、その他
  • 神経インターベンション装置のグローバル市場（2023-2032）：ステント、塞栓コイル、カテーテル、ワイヤー、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23SEP138 )"脊髄刺激装置のグローバル市場（2023-2032）：充電式装置、非充電式装置" (英文：Spinal Cord Stimulation Devices Market By Product (Rechargeable devices, Non-rechargeable devices), By Indication (Failed back surgery syndrome, Complex regional pain syndrome, Degenerative disc disease, Others), By End User (Hospitals, Ambulatory surgical centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。